Annual Report of F.Y: 2024-25 is attached herewith

Gujarat Terce Laboratories filed its Annual Report for FY25 along with the notice of its 40th AGM to be held on 21st August 2025 via video conferencing. The company crossed the ₹50 crore revenue mark for the first time, with revenue from operations rising ~4.6% to ₹5,019.52 lakh. EBITDA jumped 164% to ₹419.04 lakh, lifting margins to 8.35% from 3.31%. Profit before tax surged over 6x to ₹339.04 lakh (highest ever), though reported net profit turned negative at ₹97.87 lakh due to a one-time provision for settling long-pending tax disputes under the Vivad Se Vishwas scheme. The company drastically cut debt (debt-equity ratio down from 0.54 to 0.15), improved collection days from 43 to 37, reduced expiry losses to 1.9%, and operated Q4 with zero borrowing. AGM resolutions include re-appointment of statutory auditors, a new secretarial auditor, regularization of an independent director, seeking approval to sell its Chhatral factory, and permission to invest up to ₹10 crore in money market instruments.